Results

Vir Biotechnology Inc.

12/07/2021 | Press release | Distributed by Public on 12/07/2021 02:57

Vir Biotechnology to Host a Call on Sotrovimab’s Retained Activity Against the Omicron SARS-CoV-2 Variant